EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells

Cristina Panuzzo, Lucrezia Pironi, Alessandro Maglione iD, Simone Rocco iD, Serena Stanga iD, Chiara Riganti iD, Joanna Kopecka iD, Muhammad Shahzad Ali iD, Barbara Pergolizzi iD, Enrico Bracco iD, Daniela Cilloni iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Cristina Panuzzo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia is a critical condition that governs survival, self-renewal, quiescence, metabolic shift and refractoriness to leukemic stem cell (LSC) therapy. The present study aims to investigate the hypoxia-driven regulation of the mammalian Target of the Rapamycin-2 (mTORC2) complex to unravel it as a novel potential target in chronic myeloid leukemia (CML) therapeutic strategies. After inducing hypoxia in a CML cell line model, we investigated the activities of mTORC1 and mTORC2. Surprisingly, we detected a significant activation of mTORC2 at the expense of mTORC1, accompanied by the nuclear localization of the main substrate phospho-Akt (Ser473). Moreover, the Gene Ontology analysis of CML patients’ CD34+ cells showed enrichment in the mTORC2 signature, further strengthening our data. The deregulation of mTOR complexes highlights how hypoxia could be crucial in CML development. In conclusion, we propose a mechanism by which CML cells residing under a low-oxygen tension, i.e., in the leukemia quiescent LSCs, singularly regulate the mTORC2 and its downstream effectors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHumansMechanistic Target of Rapamycin Complex 1SirolimusChronic DiseaseMechanistic Target of Rapamycin Complex 2Stem CellsHypoxia

Stichwörter der Autor:innen

RictorTKIhypoxialeukemic stem cellsmTORC2 complexphospho-Akt (Ser473)resistance

Substanzen

TOR Serine-Threonine KinasesMechanistic Target of Rapamycin Complex 1SirolimusMechanistic Target of Rapamycin Complex 2

Autor:innen und Institutionen

  • Department of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.
  • Department of Neuroscience Rita Levi Montalcini, Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Turin, Italy.
  • Department of Oncology, University of Turin, 10043 Turin, Italy.

ORCID-Profile: Alessandro Maglione, Simone Rocco, Serena Stanga, Chiara Riganti, Joanna Kopecka, Muhammad Shahzad Ali, Barbara Pergolizzi, Enrico Bracco, Daniela Cilloni

Förderung

  • AIRC

Zitieren

APA

Panuzzo, C., Pironi, L., Maglione, A., Rocco, S., Stanga, S., Riganti, C., Kopecka, J., Ali, M. S., Pergolizzi, B., Bracco, E., & Cilloni, D. (2023). mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021234

Vancouver

Panuzzo C, Pironi L, Maglione A, Rocco S, Stanga S, Riganti C, et al. mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021234

BibTeX
@article{Panuzzo2023,
  author = {Panuzzo, Cristina and Pironi, Lucrezia and Maglione, Alessandro and Rocco, Simone and Stanga, Serena and Riganti, Chiara and Kopecka, Joanna and Ali, Muhammad Shahzad and Pergolizzi, Barbara and Bracco, Enrico and Cilloni, Daniela},
  title = {mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021234}
}
Kostenlos starten →